EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β‐catenin at Ser552

Hepatocellular carcinoma (HCC) is one of the most common malignancies and the fourth leading cause of cancer‐related death worldwide. Our previous study showed that EYA4 functioned by suppressing growth of HCC tumor cells, but its molecular mechanism is still not elucidated. Based on the results of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiao‐Xu, Li, Jian‐Hui, Cai, Jian‐Peng, Hou, Xun, Huang, Chen‐Song, Huang, Xi‐Tai, Wang, Jie‐Qin, Li, Shi‐Jin, Xu, Qiong‐Cong, Yin, Xiao‐Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778622/
https://www.ncbi.nlm.nih.gov/pubmed/31385398
http://dx.doi.org/10.1111/cas.14159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778622/
https://www.ncbi.nlm.nih.gov/pubmed/31385398
http://dx.doi.org/10.1111/cas.14159

Ejemplares similares